RIGA, September 30. /TASS/. The World Anti-Doping Agency (WADA) might exclude medical substance meldonium from its list of the banned performance enhancing drugs, preparation developer, active member of Latvia’s Academy of Sciences Ivars Kalvins told TASS on Friday.
The drug meldonium (mildronate) was included in the list of preparations banned by the World Anti-Doping Agency from January 1, 2016. The presence of the meldonium substance in the athlete’s blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on the WADA blacklist (hormones and metabolic modulators).
"I hope that WADA would finally take into account the opinion of experts and agree that meldonium is not a doping substance," Kalvins said in an interview with TASS adding that two weeks ago he paid a visit to WADA’s headquarters and delivered a report there providing details about meldonium.
"I have explained in detail the mechanism of the preparation’s work on the body system and it undoubtedly leads to the conclusion that mildronate cannot be viewed as doping," he said. "Moreover, I have also put as an example an expert article, which was not written by us and was published in 2016, with experts saying that there were no as of yet scientific proof that meldonium is a doping drug."
"We (Kalvins and WADA) have parted hoping that the truth, in my opinion, would prevail," Kalvins added.
Following numerous positive doping tests for meldonium since the beginning of the year, WADA in April that the concentration of less than one microgram of meldonium in the body system of an athlete, whose doping tests were conducted before March 1, was acceptable and the athlete at the issue was not a subject to any sanctions whatsoever.
Meldronate is a cardiovascular preparation freely available for purchase at pharmacies across Russia without doctor’s prescription.